X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (69) 69
nanoparticles (57) 57
lipid-polymer hybrid nanoparticles (46) 46
humans (42) 42
drug delivery systems (41) 41
pharmacology & pharmacy (39) 39
polymers (39) 39
nanoparticles - chemistry (38) 38
drugs (35) 35
lipids - chemistry (35) 35
drug-delivery (34) 34
lipids (33) 33
animals (29) 29
polymers - chemistry (27) 27
vehicles (27) 27
cell line, tumor (25) 25
nanoscience & nanotechnology (25) 25
cancer (24) 24
in-vitro (24) 24
liposomes (23) 23
drug delivery (19) 19
doxorubicin (17) 17
polymer industry (17) 17
particle size (16) 16
materials science, biomaterials (15) 15
female (14) 14
mice (14) 14
polymer (14) 14
analysis (13) 13
chemistry, multidisciplinary (13) 13
chemotherapy (13) 13
materials science, multidisciplinary (13) 13
nanopartikel (13) 13
lipide (12) 12
lipid–polymer hybrid nanoparticles (12) 12
antineoplastic agents - administration & dosage (11) 11
co-delivery (11) 11
controlled-release (11) 11
drug carriers - chemistry (11) 11
hybrid nanoparticles (11) 11
medicine, research & experimental (11) 11
mice, inbred balb c (11) 11
paclitaxel (11) 11
polymer hybrid nanoparticles (11) 11
antineoplastic agents - chemistry (10) 10
cell survival - drug effects (10) 10
drug delivery systems - methods (10) 10
formulation (10) 10
lipid polymer hybrid nanoparticles (10) 10
nanoparticles - administration & dosage (10) 10
nanotechnology (10) 10
plga (10) 10
release (10) 10
targeted delivery (10) 10
therapy (10) 10
biocompatibility (9) 9
breast cancer (9) 9
cellular uptake (9) 9
engineering, biomedical (9) 9
in-vivo (9) 9
lactic acid - chemistry (9) 9
polyethylene glycol (9) 9
polyethylene glycols - chemistry (9) 9
polyglycolic acid - chemistry (9) 9
toxicity (9) 9
chemistry, physical (8) 8
cisplatin (8) 8
delivery (8) 8
gene delivery (8) 8
mice, nude (8) 8
nanocarriers (8) 8
nanostructure (8) 8
optimization (8) 8
polymeric nanoparticles (8) 8
article (7) 7
cancer therapies (7) 7
carriers (7) 7
cells (7) 7
coated plga nanoparticles (7) 7
combination therapy (7) 7
doxorubicin - chemistry (7) 7
drug (7) 7
drug carriers (7) 7
drug liberation (7) 7
health aspects (7) 7
in-vivo evaluation (7) 7
lipid/polymer particle assemblies (7) 7
nanomedicine (7) 7
original research (7) 7
plga nanoparticles (7) 7
polymer science (7) 7
apoptosis (6) 6
bioavailability (6) 6
core-shell nanoparticles (6) 6
cytotoxicity (6) 6
delivery platform (6) 6
drug carriers - metabolism (6) 6
hela cells (6) 6
lipid-polymer hybrid (6) 6
lipid-polymer nanoparticles (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 11/2013, Volume 85, Issue 3, pp. 427 - 443
Journal Article
NANOTECHNOLOGY, ISSN 0957-4484, 06/2017, Volume 28, Issue 25, p. 255101
Currently, photoresponsive nanomaterials are particularly attractive due to their spatial and temporal controlled drug release abilities. In this work, we... 
NEAR-INFRARED LIGHT | PHYSICS, APPLIED | controlled drug release | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | ANTICANCER DRUG | NANOSCIENCE & NANOTECHNOLOGY | MICELLES | lipid-polymer hybrid nanoparticles | CHEMOTHERAPY | ROBUST | NANOMEDICINES | photoresponsive | IN-VIVO | UP-CONVERSION NANOPARTICLES | INTRACELLULAR DRUG
Journal Article
Drug Delivery, ISSN 1071-7544, 01/2019, Volume 26, Issue 1, pp. 765 - 772
Lipid-polymer hybrid nanoparticles (LPHNP) are delivery systems for controlled drug delivery at tumor sites. The superior biocompatible properties of lipids... 
pharmacokinetics | chitosan | controlled release | lipid-polymer hybrid nanoparticles | ovarian cancer | Cisplatin | SYSTEM | MICROSPHERES | DRUG-DELIVERY | CONTROLLED-RELEASE | TOXICITY | IN-VITRO | PHARMACOLOGY & PHARMACY | ORAL DELIVERY
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 11/2017, Volume 533, Issue 1, pp. 156 - 168
Journal Article
JOURNAL OF MICROBIOLOGICAL METHODS, ISSN 0167-7012, 05/2019, Volume 160, pp. 130 - 142
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 03/2015, Volume 10, pp. 2101 - 2114
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 46, pp. 13 - 25
Abstract Hypoxia-inducible factor 1α (HIF1α) has emerged as a promising new target for pancreatic cancer treatment over the past decade. High expression of... 
Advanced Basic Science | Dentistry | siRNA delivery | Hypoxia-inducible factor 1α | Lipid-polymer hybrid nanoparticles | Combination therapy | Orthotopic tumor model | Pancreatic cancer | SiRNA delivery | RNA INTERFERENCE | THERAPEUTICS | MATERIALS SCIENCE, BIOMATERIALS | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | Hypoxia-inducible factor 1 alpha | ENHANCED ANTITUMOR EFFICACY | THERAPY | HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | IN-VIVO | TUMOR-GROWTH | EXPRESSION | Nanoparticles - chemistry | Biocompatible Materials - chemistry | Humans | Deoxycytidine - pharmacology | Hypoxia-Inducible Factor 1, alpha Subunit | Drug Delivery Systems | Gene Knockdown Techniques | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Lipids - chemistry | Lysosomes - metabolism | Interleukin-6 - blood | Female | Disease Models, Animal | Lysosomes - drug effects | Gene Transfer Techniques | Pancreatic Neoplasms - blood | Endocytosis - drug effects | Kaplan-Meier Estimate | Nanoparticles - ultrastructure | Static Electricity | Particle Size | Animals | Mice, Nude | Interferon-alpha - blood | Cell Line, Tumor | Polymers - chemistry | Cell Proliferation - drug effects | Mice, Inbred BALB C | RNA, Small Interfering - administration & dosage | Deoxycytidine - analogs & derivatives | Serum - chemistry | Nanoparticles | Drugs | Surgical implants | Biomedical materials | Drug delivery systems | Biocompatibility | Lipids | Tumors | Cancer
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 11/2019, Volume 519, Issue 2, pp. 316 - 322
Tilianin (TIL) may prevent and treat myocardial ischemia reperfusion injuries. However, its oral administration is hampered by its low bioavailability. The... 
Lipid-polymer hybrid nanoparticles | Oral bioavailability | Tilianin | Pharmacokinetic | Self-assembly method | Nanoparticles | Chemical properties | Polymer industry | Polymers | Analysis
Journal Article